Treatment of Cellulitis
The recommended first-line treatment for typical non-purulent cellulitis is a 5-day course of an antibiotic active against streptococci, such as penicillin, amoxicillin, dicloxacillin, cephalexin, or clindamycin. 1, 2
Assessment and Classification
- Assess for systemic signs of infection to determine severity and appropriate treatment setting 1
- Cellulitis is a diffuse, superficial, spreading skin infection characterized by rapidly spreading areas of erythema, swelling, tenderness, and warmth 3
- Cultures of blood or cutaneous aspirates are not routinely recommended for typical cases of cellulitis 1, 3
- Blood cultures should be obtained for patients with malignancy, severe systemic features, or unusual predisposing factors 1, 3
Antibiotic Selection Based on Severity
Mild Non-purulent Cellulitis
Moderate to Severe Non-purulent Cellulitis
- Consider coverage for both streptococci and methicillin-susceptible S. aureus (MSSA) 1
- For patients with systemic signs of infection, many clinicians include coverage against MSSA 3
- For severe infections, vancomycin plus either piperacillin-tazobactam or imipenem-meropenem is recommended as a reasonable empiric regimen 3
MRSA Considerations
- MRSA is an unusual cause of typical cellulitis, and treatment specifically targeting MRSA is usually unnecessary 2
- Consider MRSA coverage only in specific situations:
Duration of Treatment
- A 5-day course of antimicrobial therapy is recommended for uncomplicated cellulitis 1, 2
- Treatment should be extended if the infection has not improved within 5 days 1, 3
- Studies have shown that a 5-day course is as effective as a 10-day course if clinical improvement occurs by day 5 2, 3
Treatment Setting
- Outpatient therapy is recommended for patients without SIRS, altered mental status, or hemodynamic instability 1, 3
- Hospitalization is recommended for patients with:
Adjunctive Measures
- Elevation of the affected area to promote gravity drainage of edema and inflammatory substances 1, 2
- Treatment of predisposing factors such as edema, obesity, eczema, venous insufficiency, and toe web abnormalities 1
- Consider systemic corticosteroids in non-diabetic adult patients to reduce inflammation and hasten resolution 2
- Some evidence suggests that adding anti-inflammatory therapy (such as ibuprofen) to antibiotic treatment may hasten resolution of cellulitis-related inflammation 5
Prevention of Recurrence
- Identify and treat predisposing conditions such as edema, obesity, eczema, venous insufficiency, and toe web abnormalities 1
- In lower extremity cellulitis, carefully examine the interdigital toe spaces and treat fissuring, scaling, or maceration to reduce recurrence 3
- For patients with 3-4 episodes of cellulitis per year despite treatment of predisposing factors, consider prophylactic antibiotics 1
Common Pitfalls to Avoid
- Don't extend treatment unnecessarily beyond 5 days if clinical improvement has occurred 2
- Don't automatically add MRSA coverage for typical non-purulent cellulitis without specific risk factors 2, 3
- Don't confuse cellulitis with cutaneous inflammation associated with collections of pus (such as septic bursitis, furuncles, or skin abscesses), which primarily require drainage rather than antibiotics 3
- Don't overlook underlying conditions that may predispose to recurrent cellulitis 6